Taiwan Medical Device Regulations: Complete Guide for Global Manufacturers

Bringing a medical device to Taiwan involves far more than simply showing an existing US FDA clearance, EU CE mark, or NMPA approval. To successfully enter this market, manufacturers must navigate Taiwan’s medical device regulations — an independent framework governed by the Taiwan Food and Drug Administration (TFDA) under the Medical Devices Act.

Rather than treating Taiwan as an afterthought or an extension of another region, overseas manufacturers must build a dedicated compliance strategy from day one. This means understanding how product classification, manufacturing facility approvals, local representation, and post-market controls all connect.

Here is a complete look at how Taiwan’s medical device regulations work together across the entire product lifecycle, and what you need to know to secure and maintain market access. For support with your application, explore Cisema’s medical device registration services in Taiwan or contact our team today.

The Taiwan Legislative Hierarchy: How the Law Is Structured

On May 1, 2021, Taiwan officially enacted its standalone Medical Devices Act, transitioning away from general pharmaceutical regulations.

Today, regulatory oversight flows down through a clear, three-tiered legal hierarchy:

The Primary Statute: The Medical Devices Act (醫療器材管理法)

Passed by Taiwan’s legislative branch and effective since May 2021, this primary statute sets the ground rules, defining device classifications, license ownership, manufacturing standards, and post-market obligations. Every rule down the chain traces back to this foundational law.

The Implementing Framework: The Enforcement Rules of the Medical Devices Act (醫療器材管理法施行細則)

If the Act gives us the "what," the Enforcement Rules provide the "how." Published alongside the Act in May 2021, this administrative framework outlines the procedural mechanics required to execute the law, setting key legal definitions, application procedures, and review timelines.

Subordinate Regulations and Administrative Guidance

At the operational level, specialized regulations dictate technical requirements across specific operational areas:

• Product Registration: The Regulations Governing Management of Medical Device Registration and License Issuance set documentation, clinical data, and testing requirements according to Class I, II, or III risk levels.
• Quality Systems: The Medical Device Quality Management System Regulations (QSD/QMS framework) and the Regulations Governing Good Distribution Practice of Medical Devices (GDP) govern manufacturing and distribution quality. Manufacturers must obtain TFDA manufacturing approval where required before launch, while dealers handling TFDA-announced device categories must comply with GDP requirements.
• Post-Market Surveillance: Regulations governing medical device safety surveillance and recalls establish requirements for adverse event reporting, field safety corrective actions (FSCAs), and phased Unique Device Identification (UDI) compliance.

To keep pace with innovation, the TFDA continuously releases administrative notifications and technical guidance, covering fast-evolving areas like cybersecurity (Guidance for Industry on Management of Cybersecurity in Medical Devices), Software as a Medical Device (SaMD), and AI/ML diagnostics.

Regulatory Oversight: Primary Competent Authorities

Knowing which authorities evaluate your submissions is just as critical as understanding the rules themselves. Market oversight in Taiwan rests with two key government entities, supported by a specialized technical review body:

Ministry of Health and Welfare (MOHW)

As the cabinet-level ministry responsible for public health, the MOHW sets Taiwan’s broader healthcare strategy, develops foundational health policies, and enacts regulations authorized under the Medical Devices Act. While the MOHW provides overall policy and regulatory direction, day-to-day enforcement falls to its dedicated health agency.

Taiwan Food and Drug Administration (TFDA)

Operating under the MOHW, the TFDA is the competent authority responsible for regulatory enforcement across the product lifecycle. Medical devices fall specifically under the TFDA’s Division of Medical Devices and Cosmetics.

Its key responsibilities include: 

• Pre-Market Reviews: Approving product license registrations, renewals, and major dossier amendments.
• Quality Audits: Issuing and maintaining Quality System Documentation (QSD/QMS) certifications for foreign and domestic manufacturing facilities.
• Market Oversight: Supervising Good Distribution Practice (GDP) compliance, tracking Unique Device Identification (UDI) implementation, and leading post-market safety surveillance.

Center for Drug Evaluation (CDE)

The Center for Drug Evaluation (CDE) is a government-sponsored nonprofit foundation commissioned by the MOHW and TFDA. It conducts detailed scientific and technical evaluations of high-risk Class III devices, innovative technologies, and clinical trial protocols.

The TFDA makes final regulatory decisions and issues licenses, while CDE reviewers assess technical dossiers, predicate comparisons, and clinical evidence.

Pre-Market Compliance: Classification & Submission Pathways

Successful pre-market entry begins with identifying the correct statutory pathway under Article 25 of the Medical Devices Act. Under the Regulations Governing the Classification of Medical Devices (醫療器材分類分級管理辦法), the TFDA classifies products across 16 medical specialties and three risk tiers:

Class I Devices (Online Listing)

Eligible low-risk devices on the TFDA’s pre-approved schedule may qualify for online listing. Unlike full licenses, these listings do not follow a 5-year expiration cycle; holders must instead submit an annual declaration every October to maintain their entries in the TFDA database.

Class II and Class III Devices (Full Registration)

Applicants must submit comprehensive technical documentation, risk management files, testing reports, and clinical evidence to secure a formal Medical Device License. These licenses are valid for 5 years. Renewal applications, accompanied by an updated certificate of manufacture and sale from the country of origin (製售證明) and current labelling, must be submitted to the TFDA before expiration.

Note: Certain Class II devices with existing US or EU approvals may qualify for streamlined documentation pathways, though they still undergo formal registration review.

Technical Considerations for Specialized Device Categories

Complex and digital health technologies may be subject to additional regulatory requirements during pre-market evaluation:

In Vitro Diagnostics (IVDs)

Evaluated under dedicated classification schedules in Annex I of the registration rules. Beyond core safety data, TFDA reviewers scrutinize analytical performance validation (sensitivity, specificity, cross-reactivity), clinical accuracy, matrix comparisons, and lot-to-lot calibrator traceability to recognized international standards.

Software as a Medical Device (SaMD) & AI/ML

Software-based devices undergo evaluation informed by IEC 62304 lifecycle processes and TFDA guidance for AI/ML medical devices. Applicants must demonstrate appropriate separation of training and validation datasets, performance metrics such as ROC curves, and compliance with applicable medical device cybersecurity guidance.

Innovative & Breakthrough Devices

Under the MOHW’s Regulations Governing Priority Consultation and Accelerated Assessment of Innovative Medical Devices, qualifying breakthrough technologies can secure priority consultation, assigned pre-submission case managers, and expedited review pathways, often paired with conditional post-market surveillance obligations.

Facility Compliance: Manufacturing Standards & QSD Approval

Product approval is only half the pre-market requirement. Where QSD approval is required, the TFDA will not issue a medical device license until the manufacturing facility meets applicable quality standards under Taiwan’s Medical Device Quality Management System Regulations.

While QSD requirements are anchored in ISO 13485 standards, an ISO certificate alone will not suffice. Overseas manufacturers must submit a comprehensive QSD application for TFDA review, including their quality manual, facility layouts, and operational procedures. Approximately 125 low-risk, non-sterile Class I device categories are exempt from QSD requirements.

QSD and product registration dossiers may be submitted in parallel, but the TFDA will not grant the final license until QSD approval is officially issued. Crucially, the site address, manufacturing scope, and operational activities listed across both applications must match exactly.

Once granted, manufacturing site approvals are valid for 3 years. To maintain uninterrupted compliance and ensure your product license remains active, foreign plants must initiate re-assessment under QMS Inspection regulations 6 to 12 months before expiration.

Market Access Footprint: Legal In-Country Representation

Overseas manufacturers must establish a local regulatory presence alongside their product and QSD filings. Foreign entities cannot directly hold a medical device license or listing; they must partner with a Taiwan-based entity holding a valid Medical Device Dealer License registered with the local health bureau.

Taiwan does not recognize a standalone "Authorized Representative" who only handles regulatory filings. Under the Medical Devices Act, your local partner acts as the official License Holder (or Listing Holder):

• The Local License Holder owns the regulatory record, manages all formal communications with the TFDA, submits variation filings, and holds primary responsibility for post-market safety communications.
• Importers and Distributors handle physical logistics and commercial sales. Under Article 25, these duties can be assigned to the license holder or authorized third parties, provided every participating company holds a valid dealer registration and, where it handles TFDA-announced device categories, complies with Good Distribution Practice (GDP) requirements.
• The Overseas Manufacturer retains ultimate responsibility for product design, safety, quality management, technical file maintenance, and assisting with adverse event investigations.

Post-Market Compliance & Ongoing Regulatory Maintenance

Market authorization marks the beginning of ongoing lifecycle management. The Medical Devices Act ties supply chain controls, device traceability, and safety monitoring together through several key regulations:

• Change Management (Variations): Changes to device specifications, intended use, manufacturing location, QSD scope, or Traditional Chinese labeling and instructions for use (IFUs) may require a variation filing before the updated product can be distributed.
• Good Distribution Practice (GDP): Dealers handling designated products must obtain GDP certification to verify that storage and transport conditions preserve product integrity (Regulations Governing Good Distribution Practice of Medical Devices).
• Traceability & UDI: Supply chain entities must maintain transaction logs and register Unique Device Identification (UDI) data in the TFDA’s central database (Regulations Governing Establishment and Management of Source and Distribution Records).
• Vigilance & Safety Reporting: Local license holders and foreign manufacturers must maintain protocols to investigate complaints and report serious adverse events to the TFDA within tight statutory deadlines (Regulations Governing Reporting of Serious Adverse Events).
• Active Safety Surveillance: High-risk, novel, or implantable devices may be subject to mandatory post-market surveillance, requiring license holders to submit Periodic Safety Update Reports (PSURs) (Regulations Governing Safety Monitoring of Medical Devices).
• Recalls & Corrections: If a safety defect or hazard emerges, field safety corrective actions (FSCAs) and product recalls must be executed strictly under the Regulations Governing Recall of Medical Devices.

Building a Successful Medical Device Market Entry Strategy for Taiwan

Taiwan offers a transparent and structured medical device market built on internationally recognized risk-management principles. However, foreign manufacturers frequently encounter delays when they assume an overseas approval can be automatically converted into a local license.

By approaching Taiwan as an independent regulatory jurisdiction from the beginning — and aligning your local representation, QSD facility approvals, registration dossiers, and post-market procedures — you can navigate the approval process efficiently and ensure long-term commercial success.

Entering Taiwan’s medical device market doesn’t have to be a complex, drawn-out process. With Cisema’s regulatory expertise and local presence in Taiwan, you have a partner to guide you through every stage, from classification and medical device registration to QSD approval, local representation, and ongoing compliance.

For support in registering your medical device in Taiwan, contact Cisema today.

Further Information

• Explore Cisema’s Taiwan medical device registration services
• Read Cisema’s guide to Taiwan medical device classification.
• Learn more about the TFDA in our article: What is the TFDA? An Overview for Medical Device Manufacturers

References

• Enforcement Rules of the Medical Devices Act (醫療器材管理法施行細則): Laws & Regulations Database, Ministry of Justice (MOJ)
• Medical Device Cybersecurity Guidelines for Manufacturers (適用於製造業者之醫療器材網路安全指引): TFDA
• Medical Device Quality Management System Regulations (醫療器材品質管理系統準則): TFDA
• Medical Devices Act (醫療器材管理法): Laws & Regulations Database, MOJ
• Regulations for Good Distribution Practice of Medical Devices (醫療器材優良運銷準則): TFDA
• Regulations Governing Classification of Medical Devices (醫療器材分類分級管理辦法): TFDA
• Regulations Governing Establishment and Management of Source and Distribution Records (醫療器材來源流向資料建立及管理辦法): Laws & Regulations Database, MOJ
• Regulations Governing Issuance of Medical Device License, Listing and Annual Declaration (醫療器材許可證核發與登錄及年度申報準則): TFDA
• Priority Review Mechanism for Medical Device Inspection and Registration (醫療器材查驗登記優先審查機制): TFDA
• Regulations Governing QMS Inspection and Issuance of Manufacturing Approval (醫療器材品質管理系統檢查及製造許可核發辦法): Laws & Regulations Database, MOJ‍
• Regulations Governing Recall of Medical Devices (醫療器材回收處理辦法): Laws & Regulations Database, MOJ‍
• Regulations Governing Reporting of Serious Adverse Events (醫療器材嚴重不良事件通報辦法): Laws & Regulations Database, MOJ‍
• Regulations Governing Safety Monitoring of Medical Devices (醫療器材安全監視管理辦法): Laws & Regulations Database, MOJ‍
• Regulations on Good Clinical Practice for Medical Devices: TFDA
• TFDA – Medical Devices (English): Taiwan Food and Drug Administration

‍